헬리코박터 파일로리 제균 치료로서 순차 치료는 표준 삼제요법을 대치할 수 있을까?
Sang Gyun Kim · 2023
Read 헬리코박터 파일로리 제균 치료로서 순차 치료는 표준 삼제요법을 대치할 수 있을까? by Sang Gyun Kim (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11967523.txt.
Description
Sang Gyun Kim wrote a 2023 Korean-language editorial asking whether a staged drug course can replace the standard triple therapy for clearing Helicobacter pylori, a stomach bacterium tied to ulcers and cancer. In Korea, the standard three-drug course was long the only covered first option, yet cure rates have slipped below eighty percent. The staged course gives one antibiotic for five days, then two others for five more, aiming to weaken the bacterial wall first.
Korean trial data put the staged course ahead of the standard one, and the study under discussion reached a higher cure rate still. Side effects ran slightly higher, though rarely enough to stop treatment. Second-line therapy worked less well after staged failure, hinting at resistance. Kim calls for trials of tailored therapy based on resistance testing.
Catalog record
| CREATOR | Sang Gyun Kim |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 5 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |